375 related articles for article (PubMed ID: 1195129)
1. Effects of route of administration and blood flow on hepatic drug elimination.
Shand DG; Kornhauser DM; Wilkinson GR
J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
[TBL] [Abstract][Full Text] [Related]
2. Discrimination between the venous equilibrium and sinusoidal models of hepatic drug elimination in the isolated perfused rat liver by perturbation of propranolol protein binding.
Jones DB; Morgan DJ; Mihaly GW; Webster LK; Smallwood RA
J Pharmacol Exp Ther; 1984 May; 229(2):522-6. PubMed ID: 6716274
[TBL] [Abstract][Full Text] [Related]
3. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
4. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different clearance estimates for metoprolol in the rhesus monkey.
Rane A; Högstedt S; Lindberg B; Regårdh CG; Jorulf H
J Pharmacol Exp Ther; 1984 Mar; 228(3):774-8. PubMed ID: 6707925
[TBL] [Abstract][Full Text] [Related]
6. Effects of dl-propranolol on lidocaine disposition in the perfused rat liver.
Vu VT; Chen CP
Drug Metab Dispos; 1982; 10(4):350-5. PubMed ID: 6126333
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of propranolol: a review.
Shand DG
Postgrad Med J; 1976; 52 Suppl 4():22-25. PubMed ID: 787953
[TBL] [Abstract][Full Text] [Related]
8. Role of the hepatic artery in the metabolism of phenacetin and acetaminophen: intravital microscopic and multiple-indicator dilution study in perfused rat liver.
Pang KS; Sherman IA; Schwab AJ; Geng W; Barker F; Dlugosz JA; Cuerrier G; Goresky CA
Hepatology; 1994 Sep; 20(3):672-83. PubMed ID: 8076925
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluoro-2'-deoxyuridine elimination by the isolated perfused rat liver.
Csaky KG; LaCreta FP; Warren BS; Williams WM
Cancer Res; 1988 Jul; 48(13):3561-5. PubMed ID: 2967734
[TBL] [Abstract][Full Text] [Related]
10. Influence of route of hepatic administration on drug availability.
Ahmad AB; Bennett PN; Rowland M
J Pharmacol Exp Ther; 1984 Sep; 230(3):718-25. PubMed ID: 6470976
[TBL] [Abstract][Full Text] [Related]
11. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
[TBL] [Abstract][Full Text] [Related]
12. Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion.
Iwasaki T; Ku Y; Kusunoki N; Tominaga M; Fukumoto T; Muramatsu S; Kuroda Y
Cancer Res; 1998 Aug; 58(15):3339-43. PubMed ID: 9699664
[TBL] [Abstract][Full Text] [Related]
13. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
Imawaka H; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
[TBL] [Abstract][Full Text] [Related]
14. Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patients.
Wagner JG; Gyves JW; Stetson PL; Walker-Andrews SC; Wollner IS; Cochran MK; Ensminger WD
Cancer Res; 1986 Mar; 46(3):1499-506. PubMed ID: 3943107
[TBL] [Abstract][Full Text] [Related]
15. Increased clearance of antipyrine and d-propranolol after phenobarbital treatment in the monkey. Relative contributions of enzyme induction and increased hepatic blood flow.
Branch RA; Shand DG; Wilkinson GR; Nies AS
J Clin Invest; 1974 Apr; 53(4):1101-7. PubMed ID: 4205524
[TBL] [Abstract][Full Text] [Related]
16. Reduction of liver blood flow and propranolol metabolism by cimetidine.
Feely J; Wilkinson GR; Wood AJ
N Engl J Med; 1981 Mar; 304(12):692-5. PubMed ID: 7464861
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
18. A new model-independent physiological approach to study hepatic drug clearance and its applications.
Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
[TBL] [Abstract][Full Text] [Related]
19. Dose and flow dependence of 5-fluorouracil elimination by the isolated perfused rat liver.
Warren BS; LaCreta FP; Kornhauser DM; Williams WM
Cancer Res; 1987 Oct; 47(20):5261-5. PubMed ID: 3652033
[TBL] [Abstract][Full Text] [Related]
20. Portal levels and hepatic clearance of 5-fluorouracil after intraperitoneal administration in humans.
Speyer JL; Sugarbaker PH; Collins JM; Dedrick RL; Klecker RW; Myers CE
Cancer Res; 1981 May; 41(5):1916-22. PubMed ID: 7214359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
